HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chae-Myeong Ha Selected Research

pyruvate dehydrogenase kinase 4

1/2017Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury.
1/2016Corrigendum: Pyruvate Dehydrogenase Kinase 4 Promotes Vascular Calcification via SMAD1/5/8 Phosphorylation.
11/2015Pyruvate Dehydrogenase Kinase 4 Promotes Vascular Calcification via SMAD1/5/8 Phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chae-Myeong Ha Research Topics

Disease

5Heart Failure
01/2021 - 01/2019
5Vascular Calcification
01/2016 - 02/2012
4Mitochondrial Diseases (Mitochondrial Disease)
10/2020 - 02/2012
3Obesity
10/2021 - 01/2019
2Insulin Resistance
01/2019 - 10/2016
2Inflammation (Inflammations)
01/2019 - 01/2016
2Type 2 Diabetes Mellitus (MODY)
10/2017 - 01/2017
2Metabolic Diseases (Metabolic Disease)
01/2017 - 01/2016
1Hypoxia (Hypoxemia)
01/2022
1Cardiogenic Shock
01/2022
1Carcinoma (Carcinomatosis)
10/2021
1Neoplasms (Cancer)
10/2021
1Diabetic Cardiomyopathies
10/2020
1Hyperglycemia
10/2020
1Glucose Intolerance
01/2020
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020
1Left Ventricular Dysfunction
01/2020
1Coronary Disease (Coronary Heart Disease)
01/2019
1Acute Kidney Injury (Acute Renal Failure)
01/2017
1Atherosclerosis
11/2015
1Fibrosis (Cirrhosis)
10/2014
1Hyperphosphatemia
10/2014
1Vascular Diseases (Vascular Disease)
10/2014

Drug/Important Bio-Agent (IBA)

3Glucose (Dextrose)FDA LinkGeneric
10/2021 - 10/2016
3AntioxidantsIBA
01/2020 - 02/2012
3CalciumIBA
01/2017 - 10/2014
3pyruvate dehydrogenase kinase 4IBA
01/2017 - 11/2015
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2019
2Proteins (Proteins, Gene)FDA Link
10/2021 - 11/2015
2Adenosine Triphosphate (ATP)IBA
01/2017 - 02/2012
2Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
10/2016 - 11/2015
2Phosphates (Orthophosphate)IBA
11/2015 - 02/2012
1Biomarkers (Surrogate Marker)IBA
01/2022
1Metformin (Glucophage)FDA LinkGeneric
10/2021
1CollagenIBA
10/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1hexosaminidase CIBA
01/2020
1mitoquinoneIBA
01/2020
1Blood Glucose (Blood Sugar)IBA
01/2020
1Coenzyme A (CoA)IBA
01/2020
1Hydroxybutyrate Dehydrogenase (3 Hydroxybutyrate Dehydrogenase)IBA
01/2020
1KetonesIBA
01/2020
1Streptozocin (Streptozotocin)FDA Link
01/2020
1TransferasesIBA
01/2020
1succinyl-coenzyme A (succinyl-CoA)IBA
01/2020
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2020
1Nuclear Respiratory Factor 1IBA
10/2019
1empagliflozinIBA
02/2019
1Insulin (Novolin)FDA Link
01/2019
1EnzymesIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1MethyltransferasesIBA
01/2019
1Polychlorinated Biphenyls (PCBs)IBA
10/2017
1Persistent Organic PollutantsIBA
10/2017
1PalmitatesIBA
01/2017
1Dichloroacetic AcidIBA
01/2017
1Cisplatin (Platino)FDA LinkGeneric
01/2017
1Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
01/2017
1Nonesterified Fatty Acids (NEFA)IBA
01/2017
1Caspase 3 (Caspase-3)IBA
01/2017
1Malonyl Coenzyme A (Malonyl CoA)IBA
10/2016
1Pyruvic Acid (Pyruvate)IBA
10/2016
1Tricarboxylic AcidsIBA
10/2016
1InflammasomesIBA
01/2016
1GSK5182IBA
11/2015
1Small Interfering RNA (siRNA)IBA
11/2015
1Bone Morphogenetic Protein 2IBA
11/2015
1Estrogens (Estrogen)FDA Link
11/2015
1Dimethyl FumarateIBA
10/2014
1NF-E2-Related Factor 2IBA
10/2014
1VitaminsIBA
10/2014
1Cytochromes c (Cytochrome c)IBA
02/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2012
1Caspase 9IBA
02/2012
1Thioctic Acid (Lipoic Acid)IBA
02/2012

Therapy/Procedure

1Therapeutics
10/2021
1Transplantation
01/2019
1Immunomodulation
10/2014